BNKL Stock Overview
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Bionik Laboratories Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$1.45 |
52 Week Low | US$0.000001 |
Beta | -1.24 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
BNKL | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 1.8% | 1.2% |
1Y | n/a | -0.5% | 24.9% |
Return vs Industry: Insufficient data to determine how BNKL performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how BNKL performed against the US Market.
Price Volatility
BNKL volatility | |
---|---|
BNKL Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BNKL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BNKL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 12 | Rich Russo | www.bioniklabs.com |
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
Bionik Laboratories Corp. Fundamentals Summary
BNKL fundamental statistics | |
---|---|
Market cap | US$12.00 |
Earnings (TTM) | -US$4.95m |
Revenue (TTM) | US$1.81m |
0.0x
P/S Ratio0.0x
P/E RatioIs BNKL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BNKL income statement (TTM) | |
---|---|
Revenue | US$1.81m |
Cost of Revenue | US$815.33k |
Gross Profit | US$989.88k |
Other Expenses | US$5.94m |
Earnings | -US$4.95m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.39 |
Gross Margin | 54.83% |
Net Profit Margin | -273.99% |
Debt/Equity Ratio | -131.4% |
How did BNKL perform over the long term?
See historical performance and comparison